Protagonist Therapeutics (NASDAQ:PTGX) has outperformed the market over the past 10 years by 6.99% on an annualized basis producing an average annual return of 20.58%. Currently, Protagonist Therapeutics has a market capitalization of $9.22 billion.
Buying $100 In PTGX: If an investor had bought $100 of PTGX stock 10 years ago, it would be worth $668.69 today based on a price of $142.50 for PTGX at the time of writing.
Protagonist Therapeutics’s Performance Over Last 10 Years
Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to comment